Function blocking antibodies of CD44, a uropod-associated protein, inhibited the homing capacity of HSC/HPC and that of AML and CML cells [57], [58], [59], [60], [61], and reduce metastasis of these cells [60], [61]. This evidence concerns the gene CD44 and chronic myelogenous leukemia, BCR-ABL1 positive.